By Grey Moran
As avian flu decimated poultry flocks, two major U.S. egg producers - Vital Farms and Cal-Maine - have seen their profits and stock values soar. Between February 2024 and February 2025, Vital Farms saw its share value spike by 157.4 percent, while Cal-Maine observed an 87.4 percent uptick. These climbing stocks coincided with sky-high egg prices, often attributed to the shrinking egg supply, leaving consumers pinched.
The financial strain faced by consumers stands in sharp contrast to the financial windfalls of major egg companies - and their investors - over the course of the avian flu outbreak in the U.S. that began in early 2022. This stark disparity is emblematic of the often inverse relationship between consumer and corporate financial pressures during economic crises.
"When eggs are short, everybody wants in," Russell Diez-Canseco, the CEO of the egg producer Vital Farms, said on a call with investors in 2023, following a quarter of record-breaking revenue, as average egg prices soared across the U.S.
Vital Farms' top institutional investors - BlackRock, Wellington Management Company, Vanguard Group, Amazon, and Pictet Asset Management, according to Nasdaq - have also benefited from the company's soaring stocks over the course of avian flu. Amazon, which owns Whole Foods, may have also benefited from higher retail prices of eggs, as well as the record-level volume of sales reported last quarter.